Infection in infancy and subsequent risk of developing lymphoma in children and young adults

Blood

Volumn 117, Issue 5, 2011, Pages 1670-1672

  Goldin, Lynn R ^a   Landgren, Ola ^a   Kristinsson, Sigurdur Y ^b   Björkholm, Magnus ^b   Paltiel, Ora ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; B CELL LYMPHOMA; CANCER PATIENT; CANCER REGISTRY; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; FEMALE; HODGKIN DISEASE; HOSPITALIZATION; HUMAN; IMMUNE DEFICIENCY; INFECTION; INTESTINE INFECTION; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; NONHODGKIN LYMPHOMA; POPULATION; PRESCHOOL CHILD; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; RISK ASSESSMENT; SCHOOL CHILD; SWEDEN;

EID: 79551626672     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-09-306274     Document Type: Article

References (16)

1. Chua I, Quinti I, Grimbacher B. Lymphoma in common variable immunodeficiency: interplay between immune dysregulation, infection and genetics. Curr Opin Hematol. 2008;15(4):368-374.
2. Engels EA. Infectious agents as causes of non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):401-404.
3. Ferreri AJ, Ernberg I, Copie-Bergman C. Infectious agents and lymphoma development: molecular and clinical aspects. J Intern Med. 2009;265(4):421-438.
4. Grulich AE, Vajdic CM, Cozen W. Altered immunity as a risk factor for non-Hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev. 2007;16(3):405-408. (Pubitemid 46548641)
5. Paltiel O, Laniado DE, Yanetz R, et al. The risk of cancer following hospitalization for infection in infancy: a population-based cohort study. Cancer Epidemiol Biomarkers Prev. 2006;15(10):1964-1968. (Pubitemid 44664275)
6. Goldin LR, Bjorkholm M, Kristinsson SY, Turesson I, Landgren O. Highly increased familial risks for specific lymphoma subtypes. Br J Haematol. 2009;146(1):91-94.
7. Kristinsson SY, Koshiol J, Bjorkholm M, et al. Immune-related and inflammatory conditions and risk of lymphoplasmacytic lymphoma or Waldenstrom macroglobulinemia. J Natl Cancer Inst. 2010;102(8):557-567.
8. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol. 2009;48(1):27-33.
9. Turesson I, Linet MS, Bjorkholm M, et al. Ascertainment and diagnostic accuracy for hematopoietic lymphoproliferative malignancies in Sweden 1964-2003. Int J Cancer. 2007;121(10):2260-2266.
10. Vento S, Tanko MN. The bacterium that could cause cancer. Lancet Oncol. 2009;10(5):528.
11. Al-Saleem T, Al-Mondhiry H. Immunoproliferative small intestinal disease (IPSID): a model for mature B-cell neoplasms. Blood. 2005;105(6):2274-2280. (Pubitemid 40387019)
12. Matsuo K, Kusano A, Sugumar A, Nakamura S, Tajima K, Mueller NE. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci. 2004;95(9):745-752. (Pubitemid 39335095)
13. Knowles DM. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am. 2003;17(3):785-820. (Pubitemid 36807598)
14. Wilks M. Bacteria and early human development. Early Hum Dev. 2007;83(3):165-170.
15. Casanova JL, Fieschi C, Bustamante J, et al. From idiopathic infectious diseases to novel primary immunodeficiencies. J Allergy Clin Immunol. 2005;116(2):426-430. (Pubitemid 41096554)
16. Clarke CA, Glaser SL. Changing incidence of non-Hodgkin lymphomas in the United States. Cancer. 2002;94(7):2015-2023. (Pubitemid 34270055)